Page last updated: 2024-09-03

5-fluorodopa and fluorodeoxyglucose f18

5-fluorodopa has been researched along with fluorodeoxyglucose f18 in 3 studies

Compound Research Comparison

Studies (5-fluorodopa)	Trials (5-fluorodopa)	Recent Studies (post-2010) (5-fluorodopa)	Studies (fluorodeoxyglucose f18)	Trials (fluorodeoxyglucose f18)	Recent Studies (post-2010) (fluorodeoxyglucose f18)
32	1	5	34,771	2,160	20,111

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K	1
Calne, DB; Eisen, A; Meneilly, G	1
Lang, AE	1

Reviews

1 review(s) available for 5-fluorodopa and fluorodeoxyglucose f18

Article	Year
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4 Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed	1995

Article

Year

Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.

Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4

Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed

1995

Other Studies

2 other study(ies) available for 5-fluorodopa and fluorodeoxyglucose f18

Article	Year
Positron emission tomography in degenerative disorders of the dopaminergic system. Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:2 Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	1992
Normal aging of the nervous system. Annals of neurology, 1991, Volume: 30, Issue:2 Topics: Aging; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Nervous System Physiological Phenomena; Reference Values	1991

Article

Year

Positron emission tomography in degenerative disorders of the dopaminergic system.

Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:2

Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1992

Normal aging of the nervous system.

Annals of neurology, 1991, Volume: 30, Issue:2

Topics: Aging; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Nervous System Physiological Phenomena; Reference Values

1991